BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 27756417)

  • 21. Respiratory movement of upper abdominal organs and its effect on radiotherapy planning in pancreatic cancer.
    Gwynne S; Wills L; Joseph G; John G; Staffurth J; Hurt C; Mukherjee S
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):713-9. PubMed ID: 19733469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiation Therapy Oncology Group consensus panel guidelines for the delineation of the clinical target volume in the postoperative treatment of pancreatic head cancer.
    Goodman KA; Regine WF; Dawson LA; Ben-Josef E; Haustermans K; Bosch WR; Turian J; Abrams RA
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):901-8. PubMed ID: 22483737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping of local recurrence after pancreaticoduodenectomy for distal extrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
    Jung W; Kim K; Min SK; Nam EM; Lee JK
    Br J Radiol; 2019 Aug; 92(1100):20190285. PubMed ID: 31145644
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comprehensive dosimetric study of pancreatic cancer treatment using three-dimensional conformal radiation therapy (3DCRT), intensity-modulated radiation therapy (IMRT), volumetric-modulated radiation therapy (VMAT), and passive-scattering and modulated-scanning proton therapy (PT).
    Ding X; Dionisi F; Tang S; Ingram M; Hung CY; Prionas E; Lichtenwalner P; Butterwick I; Zhai H; Yin L; Lin H; Kassaee A; Avery S
    Med Dosim; 2014; 39(2):139-45. PubMed ID: 24661778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gated carbon-ion scanning treatment for pancreatic tumour with field specific target volume and organs at risk.
    Miki K; Mori S; Shiomi M; Yamada S
    Phys Med; 2016 Dec; 32(12):1521-1528. PubMed ID: 27884463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PET/CT of breast cancer regional nodal recurrences: an evaluation of contouring atlases.
    Beaton L; Nica L; Tyldesley S; Sek K; Ayre G; Aparicio M; Gondara L; Speers C; Nichol A
    Radiat Oncol; 2020 Jun; 15(1):136. PubMed ID: 32487183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. External Validation and Optimization of International Consensus Clinical Target Volumes for Adjuvant Radiation Therapy in Bladder Cancer.
    Reddy AV; Christodouleas JP; Wu T; Smith ND; Steinberg GD; Liauw SL
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):740-746. PubMed ID: 28244409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Origin of tumor recurrence after intensity modulated radiation therapy for oropharyngeal squamous cell carcinoma.
    Raktoe SA; Dehnad H; Raaijmakers CP; Braunius W; Terhaard CH
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):136-41. PubMed ID: 22541959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of Relapse After Adjuvant Chemoradiation for Cervical Cancer in a Phase 3 Clinical Trial (PARCER): An Evaluation of Updated NRG Oncology/RTOG Target Delineation Guidelines.
    Mittal P; Chopra S; Charnalia M; Dora T; Engineer R; Mulani J; Scaria L; Prajapati K; Kannan S; Gurram L; Mahantshetty U; Gupta S; Shrivastava SK
    Int J Radiat Oncol Biol Phys; 2022 Jun; 113(2):369-378. PubMed ID: 35157993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience.
    Caravatta L; Macchia G; Mattiucci GC; Sainato A; Cernusco NL; Mantello G; Di Tommaso M; Trignani M; De Paoli A; Boz G; Friso ML; Fusco V; Di Nicola M; Morganti AG; Genovesi D
    Radiat Oncol; 2014 Sep; 9():198. PubMed ID: 25199768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment and topographic characterization of locoregional recurrences in head and neck tumours.
    Ferreira BC; Marques RV; Khouri L; Santos T; Sá-Couto P; do Carmo Lopes M
    Radiat Oncol; 2015 Feb; 10():41. PubMed ID: 25889988
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CT-guided intracavitary radiotherapy for cervical cancer: Comparison of conventional point A plan with clinical target volume-based three-dimensional plan using dose-volume parameters.
    Shin KH; Kim TH; Cho JK; Kim JY; Park SY; Park SY; Kim DY; Chie EK; Pyo HR; Cho KH
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):197-204. PubMed ID: 16169676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation.
    Moreno-Jiménez M; Aristu J; López-Picazo JM; Ramos LI; Gúrpide A; Gómez-Iturriaga A; Valero J; Martínez-Monge R
    Radiother Oncol; 2008 Sep; 88(3):342-50. PubMed ID: 18558448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anatomic variations due to radical prostatectomy. Impact on target volume definition and dose-volume parameters of rectum and bladder.
    Sanguineti G; Castellone P; Foppiano F; Franzone P; Marcenaro M; Tognoni P; Bolognesi A; Ceresoli GL; Fiorino C
    Strahlenther Onkol; 2004 Sep; 180(9):563-72. PubMed ID: 15378187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A treatment planning comparison of four target volume contouring guidelines for locally advanced pancreatic cancer radiotherapy.
    Fokas E; Eccles C; Patel N; Chu KY; Warren S; McKenna WG; Brunner TB
    Radiother Oncol; 2013 May; 107(2):200-6. PubMed ID: 23647755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective assessment of patterns of recurrence relative to radiotherapy volumes for adjuvant conformal chemoradiotherapy in gastric cancer.
    Conrad T; MacLellan S; Kassam Z; Mackay H; Khalili I; Sykes J; Purdie T; Okrainec A; Ringash J
    Gastric Cancer; 2016 Jul; 19(3):887-93. PubMed ID: 26362272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study.
    Comito T; Cozzi L; Zerbi A; Franzese C; Clerici E; Tozzi A; Iftode C; Navarria P; D'Agostino G; Fogliata A; Mancosu P; Tomatis S; Carnaghi C; Personeni N; Santoro A; Scorsetti M
    Eur J Surg Oncol; 2017 Apr; 43(4):735-742. PubMed ID: 28131670
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of computed tomography in radiotherapy treatment planning for breast cancer. How does conventional radiotherapy planning compare with virtual?
    Bauduceau O; Bollet MA; Pons P; Kirova YM; Fayolle M; Zervoudis S; Campana F
    J BUON; 2008; 13(2):245-51. PubMed ID: 18555473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Customized computed tomography-based boost volumes in breast-conserving therapy: use of three-dimensional histologic information for clinical target volume margins.
    Hanbeukers B; Borger J; van den Ende P; van der Ent F; Houben R; Jager J; Keymeulen K; Murrer L; Sastrowijoto S; van de Vijver K; Boersma L
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):757-63. PubMed ID: 19304402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.